|
| N-[[4-(1,1-Dimethylethyl)phenyl]methyl-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-phenylmethyl)-L-tyrosinamide Basic information |
| N-[[4-(1,1-Dimethylethyl)phenyl]methyl-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-phenylmethyl)-L-tyrosinamide Chemical Properties |
Boiling point | 753.4±60.0 °C(Predicted) | density | 1.053±0.06 g/cm3(Predicted) | storage temp. | Store at +4°C | solubility | DMSO: 100 mM; Ethanol: 100 mM | pka | 13.83±0.46(Predicted) | form | Powder |
| N-[[4-(1,1-Dimethylethyl)phenyl]methyl-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-phenylmethyl)-L-tyrosinamide Usage And Synthesis |
Description | PD 173212 is an N-type calcium channel blocker (IC50 = 36 nM). It prevents audiogenic seizures in mice when administered at a dose of 30 mg/kg. |
| N-[[4-(1,1-Dimethylethyl)phenyl]methyl-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-phenylmethyl)-L-tyrosinamide Preparation Products And Raw materials |
|